1 Blood Plasma Fractionation Market Overview
    1.1 Product Overview and Scope of Blood Plasma Fractionation
    1.2 Blood Plasma Fractionation Segment by Type
        1.2.1 Global Blood Plasma Fractionation Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Immune Globulin
        1.2.3 Coagulation Factor
        1.2.4 Albumin
        1.2.5 Others
    1.3 Blood Plasma Fractionation Segment by Application
        1.3.1 Global Blood Plasma Fractionation Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
        1.3.4 Others
    1.4 Global Blood Plasma Fractionation Market Size Estimates and Forecasts
        1.4.1 Global Blood Plasma Fractionation Revenue 2017-2028
        1.4.2 Global Blood Plasma Fractionation Sales 2017-2028
        1.4.3 Blood Plasma Fractionation Market Size by Region: 2017 Versus 2021 Versus 2028
2 Blood Plasma Fractionation Market Competition by Manufacturers
    2.1 Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Blood Plasma Fractionation Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Blood Plasma Fractionation Manufacturing Sites, Area Served, Product Type
    2.5 Blood Plasma Fractionation Market Competitive Situation and Trends
        2.5.1 Blood Plasma Fractionation Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Blood Plasma Fractionation Players Market Share by Revenue
        2.5.3 Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Plasma Fractionation Retrospective Market Scenario by Region
    3.1 Global Blood Plasma Fractionation Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Blood Plasma Fractionation Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Blood Plasma Fractionation Market Facts & Figures by Country
        3.3.1 North America Blood Plasma Fractionation Sales by Country
        3.3.2 North America Blood Plasma Fractionation Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Blood Plasma Fractionation Market Facts & Figures by Country
        3.4.1 Europe Blood Plasma Fractionation Sales by Country
        3.4.2 Europe Blood Plasma Fractionation Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Region
        3.5.1 Asia Pacific Blood Plasma Fractionation Sales by Region
        3.5.2 Asia Pacific Blood Plasma Fractionation Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
        3.6.1 Latin America Blood Plasma Fractionation Sales by Country
        3.6.2 Latin America Blood Plasma Fractionation Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
        3.7.1 Middle East and Africa Blood Plasma Fractionation Sales by Country
        3.7.2 Middle East and Africa Blood Plasma Fractionation Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Blood Plasma Fractionation Historic Market Analysis by Type
    4.1 Global Blood Plasma Fractionation Sales Market Share by Type (2017-2022)
    4.2 Global Blood Plasma Fractionation Revenue Market Share by Type (2017-2022)
    4.3 Global Blood Plasma Fractionation Price by Type (2017-2022)
5 Global Blood Plasma Fractionation Historic Market Analysis by Application
    5.1 Global Blood Plasma Fractionation Sales Market Share by Application (2017-2022)
    5.2 Global Blood Plasma Fractionation Revenue Market Share by Application (2017-2022)
    5.3 Global Blood Plasma Fractionation Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Takeda
        6.1.1 Takeda Corporation Information
        6.1.2 Takeda Description and Business Overview
        6.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Takeda Blood Plasma Fractionation Product Portfolio
        6.1.5 Takeda Recent Developments/Updates
    6.2 CSL
        6.2.1 CSL Corporation Information
        6.2.2 CSL Description and Business Overview
        6.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 CSL Blood Plasma Fractionation Product Portfolio
        6.2.5 CSL Recent Developments/Updates
    6.3 Grifols
        6.3.1 Grifols Corporation Information
        6.3.2 Grifols Description and Business Overview
        6.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Grifols Blood Plasma Fractionation Product Portfolio
        6.3.5 Grifols Recent Developments/Updates
    6.4 Octapharma
        6.4.1 Octapharma Corporation Information
        6.4.2 Octapharma Description and Business Overview
        6.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
        6.4.5 Octapharma Recent Developments/Updates
    6.5 Kedrion
        6.5.1 Kedrion Corporation Information
        6.5.2 Kedrion Description and Business Overview
        6.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
        6.5.5 Kedrion Recent Developments/Updates
    6.6 LFB Group
        6.6.1 LFB Group Corporation Information
        6.6.2 LFB Group Description and Business Overview
        6.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
        6.6.5 LFB Group Recent Developments/Updates
    6.7 Biotest
        6.6.1 Biotest Corporation Information
        6.6.2 Biotest Description and Business Overview
        6.6.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Biotest Blood Plasma Fractionation Product Portfolio
        6.7.5 Biotest Recent Developments/Updates
    6.8 BPL
        6.8.1 BPL Corporation Information
        6.8.2 BPL Description and Business Overview
        6.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 BPL Blood Plasma Fractionation Product Portfolio
        6.8.5 BPL Recent Developments/Updates
    6.9 RAAS
        6.9.1 RAAS Corporation Information
        6.9.2 RAAS Description and Business Overview
        6.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 RAAS Blood Plasma Fractionation Product Portfolio
        6.9.5 RAAS Recent Developments/Updates
    6.10 CBPO
        6.10.1 CBPO Corporation Information
        6.10.2 CBPO Description and Business Overview
        6.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 CBPO Blood Plasma Fractionation Product Portfolio
        6.10.5 CBPO Recent Developments/Updates
    6.11 Hualan Bio
        6.11.1 Hualan Bio Corporation Information
        6.11.2 Hualan Bio Blood Plasma Fractionation Description and Business Overview
        6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
        6.11.5 Hualan Bio Recent Developments/Updates
    6.12 Tiantan Bio
        6.12.1 Tiantan Bio Corporation Information
        6.12.2 Tiantan Bio Blood Plasma Fractionation Description and Business Overview
        6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
        6.12.5 Tiantan Bio Recent Developments/Updates
    6.13 Shuanglin Bio
        6.13.1 Shuanglin Bio Corporation Information
        6.13.2 Shuanglin Bio Blood Plasma Fractionation Description and Business Overview
        6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
        6.13.5 Shuanglin Bio Recent Developments/Updates
    6.14 Boya Bio
        6.14.1 Boya Bio Corporation Information
        6.14.2 Boya Bio Blood Plasma Fractionation Description and Business Overview
        6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
        6.14.5 Boya Bio Recent Developments/Updates
    6.15 Yuanda Shuyang
        6.15.1 Yuanda Shuyang Corporation Information
        6.15.2 Yuanda Shuyang Blood Plasma Fractionation Description and Business Overview
        6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
        6.15.5 Yuanda Shuyang Recent Developments/Updates
    6.16 Weiguang Bio
        6.16.1 Weiguang Bio Corporation Information
        6.16.2 Weiguang Bio Blood Plasma Fractionation Description and Business Overview
        6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
        6.16.5 Weiguang Bio Recent Developments/Updates
    6.17 Nanyue Bio
        6.17.1 Nanyue Bio Corporation Information
        6.17.2 Nanyue Bio Blood Plasma Fractionation Description and Business Overview
        6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
        6.17.5 Nanyue Bio Recent Developments/Updates
    6.18 KM Biologics
        6.18.1 KM Biologics Corporation Information
        6.18.2 KM Biologics Blood Plasma Fractionation Description and Business Overview
        6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
        6.18.5 KM Biologics Recent Developments/Updates
7 Blood Plasma Fractionation Manufacturing Cost Analysis
    7.1 Blood Plasma Fractionation Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Blood Plasma Fractionation
    7.4 Blood Plasma Fractionation Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Blood Plasma Fractionation Distributors List
    8.3 Blood Plasma Fractionation Customers
9 Blood Plasma Fractionation Market Dynamics
    9.1 Blood Plasma Fractionation Industry Trends
    9.2 Blood Plasma Fractionation Market Drivers
    9.3 Blood Plasma Fractionation Market Challenges
    9.4 Blood Plasma Fractionation Market Restraints
10 Global Market Forecast
    10.1 Blood Plasma Fractionation Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Blood Plasma Fractionation by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Blood Plasma Fractionation by Type (2023-2028)
    10.2 Blood Plasma Fractionation Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Blood Plasma Fractionation by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Blood Plasma Fractionation by Application (2023-2028)
    10.3 Blood Plasma Fractionation Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Blood Plasma Fractionation by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Blood Plasma Fractionation by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Blood Plasma Fractionation Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Blood Plasma Fractionation Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Blood Plasma Fractionation Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Blood Plasma Fractionation Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Blood Plasma Fractionation Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Blood Plasma Fractionation Manufacturing Sites and Area Served
    Table 11. Manufacturers Blood Plasma Fractionation Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Blood Plasma Fractionation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Plasma Fractionation as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Blood Plasma Fractionation Sales by Region (2017-2022) & (K Units)
    Table 16. Global Blood Plasma Fractionation Sales Market Share by Region (2017-2022)
    Table 17. Global Blood Plasma Fractionation Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Blood Plasma Fractionation Revenue Market Share by Region (2017-2022)
    Table 19. North America Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
    Table 20. North America Blood Plasma Fractionation Sales Market Share by Country (2017-2022)
    Table 21. North America Blood Plasma Fractionation Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Blood Plasma Fractionation Revenue Market Share by Country (2017-2022)
    Table 23. Europe Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Blood Plasma Fractionation Sales Market Share by Country (2017-2022)
    Table 25. Europe Blood Plasma Fractionation Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Blood Plasma Fractionation Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Blood Plasma Fractionation Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Blood Plasma Fractionation Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Blood Plasma Fractionation Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Blood Plasma Fractionation Sales Market Share by Country (2017-2022)
    Table 33. Latin America Blood Plasma Fractionation Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Blood Plasma Fractionation Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Blood Plasma Fractionation Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Blood Plasma Fractionation Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Blood Plasma Fractionation Revenue Market Share by Country (2017-2022)
    Table 39. Global Blood Plasma Fractionation Sales by Type (2017-2022) & (K Units)
    Table 40. Global Blood Plasma Fractionation Sales Market Share by Type (2017-2022)
    Table 41. Global Blood Plasma Fractionation Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Blood Plasma Fractionation Revenue Share by Type (2017-2022)
    Table 43. Global Blood Plasma Fractionation Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Blood Plasma Fractionation Sales (K Units) by Application (2017-2022)
    Table 45. Global Blood Plasma Fractionation Sales Market Share by Application (2017-2022)
    Table 46. Global Blood Plasma Fractionation Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Blood Plasma Fractionation Revenue Share by Application (2017-2022)
    Table 48. Global Blood Plasma Fractionation Price by Application (2017-2022) & (US$/Unit)
    Table 49. Takeda Corporation Information
    Table 50. Takeda Description and Business Overview
    Table 51. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Takeda Blood Plasma Fractionation Product
    Table 53. Takeda Recent Developments/Updates
    Table 54. CSL Corporation Information
    Table 55. CSL Description and Business Overview
    Table 56. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. CSL Blood Plasma Fractionation Product
    Table 58. CSL Recent Developments/Updates
    Table 59. Grifols Corporation Information
    Table 60. Grifols Description and Business Overview
    Table 61. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Grifols Blood Plasma Fractionation Product
    Table 63. Grifols Recent Developments/Updates
    Table 64. Octapharma Corporation Information
    Table 65. Octapharma Description and Business Overview
    Table 66. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Octapharma Blood Plasma Fractionation Product
    Table 68. Octapharma Recent Developments/Updates
    Table 69. Kedrion Corporation Information
    Table 70. Kedrion Description and Business Overview
    Table 71. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Kedrion Blood Plasma Fractionation Product
    Table 73. Kedrion Recent Developments/Updates
    Table 74. LFB Group Corporation Information
    Table 75. LFB Group Description and Business Overview
    Table 76. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. LFB Group Blood Plasma Fractionation Product
    Table 78. LFB Group Recent Developments/Updates
    Table 79. Biotest Corporation Information
    Table 80. Biotest Description and Business Overview
    Table 81. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Biotest Blood Plasma Fractionation Product
    Table 83. Biotest Recent Developments/Updates
    Table 84. BPL Corporation Information
    Table 85. BPL Description and Business Overview
    Table 86. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. BPL Blood Plasma Fractionation Product
    Table 88. BPL Recent Developments/Updates
    Table 89. RAAS Corporation Information
    Table 90. RAAS Description and Business Overview
    Table 91. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. RAAS Blood Plasma Fractionation Product
    Table 93. RAAS Recent Developments/Updates
    Table 94. CBPO Corporation Information
    Table 95. CBPO Description and Business Overview
    Table 96. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. CBPO Blood Plasma Fractionation Product
    Table 98. CBPO Recent Developments/Updates
    Table 99. Hualan Bio Corporation Information
    Table 100. Hualan Bio Description and Business Overview
    Table 101. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Hualan Bio Blood Plasma Fractionation Product
    Table 103. Hualan Bio Recent Developments/Updates
    Table 104. Tiantan Bio Corporation Information
    Table 105. Tiantan Bio Description and Business Overview
    Table 106. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Tiantan Bio Blood Plasma Fractionation Product
    Table 108. Tiantan Bio Recent Developments/Updates
    Table 109. Shuanglin Bio Corporation Information
    Table 110. Shuanglin Bio Description and Business Overview
    Table 111. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Shuanglin Bio Blood Plasma Fractionation Product
    Table 113. Shuanglin Bio Recent Developments/Updates
    Table 114. Boya Bio Corporation Information
    Table 115. Boya Bio Description and Business Overview
    Table 116. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Boya Bio Blood Plasma Fractionation Product
    Table 118. Boya Bio Recent Developments/Updates
    Table 119. Yuanda Shuyang Corporation Information
    Table 120. Yuanda Shuyang Description and Business Overview
    Table 121. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Yuanda Shuyang Blood Plasma Fractionation Product
    Table 123. Yuanda Shuyang Recent Developments/Updates
    Table 124. Weiguang Bio Corporation Information
    Table 125. Weiguang Bio Description and Business Overview
    Table 126. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Weiguang Bio Blood Plasma Fractionation Product
    Table 128. Weiguang Bio Recent Developments/Updates
    Table 129. Nanyue Bio Corporation Information
    Table 130. Nanyue Bio Description and Business Overview
    Table 131. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Nanyue Bio Blood Plasma Fractionation Product
    Table 133. Nanyue Bio Recent Developments/Updates
    Table 134. KM Biologics Corporation Information
    Table 135. KM Biologics Description and Business Overview
    Table 136. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. KM Biologics Blood Plasma Fractionation Product
    Table 138. KM Biologics Recent Developments/Updates
    Table 139. Production Base and Market Concentration Rate of Raw Material
    Table 140. Key Suppliers of Raw Materials
    Table 141. Blood Plasma Fractionation Distributors List
    Table 142. Blood Plasma Fractionation Customers List
    Table 143. Blood Plasma Fractionation Market Trends
    Table 144. Blood Plasma Fractionation Market Drivers
    Table 145. Blood Plasma Fractionation Market Challenges
    Table 146. Blood Plasma Fractionation Market Restraints
    Table 147. Global Blood Plasma Fractionation Sales Forecast by Type (2023-2028) & (K Units)
    Table 148. Global Blood Plasma Fractionation Sales Market Share Forecast by Type (2023-2028)
    Table 149. Global Blood Plasma Fractionation Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 150. Global Blood Plasma Fractionation Revenue Market Share Forecast by Type (2023-2028)
    Table 151. Global Blood Plasma Fractionation Sales Forecast by Application (2023-2028) & (K Units)
    Table 152. Global Blood Plasma Fractionation Sales Market Share Forecast by Application (2023-2028)
    Table 153. Global Blood Plasma Fractionation Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 154. Global Blood Plasma Fractionation Revenue Market Share Forecast by Application (2023-2028)
    Table 155. Global Blood Plasma Fractionation Sales Forecast by Region (2023-2028) & (K Units)
    Table 156. Global Blood Plasma Fractionation Sales Market Share Forecast by Region (2023-2028)
    Table 157. Global Blood Plasma Fractionation Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 158. Global Blood Plasma Fractionation Revenue Market Share Forecast by Region (2023-2028)
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Blood Plasma Fractionation
    Figure 2. Global Blood Plasma Fractionation Market Share by Type in 2021 & 2028
    Figure 3. Immune Globulin Product Picture
    Figure 4. Coagulation Factor Product Picture
    Figure 5. Albumin Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Blood Plasma Fractionation Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Retail Pharmacy
    Figure 10. Others
    Figure 11. Global Blood Plasma Fractionation Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Blood Plasma Fractionation Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Blood Plasma Fractionation Sales (2017-2028) & (K Units)
    Figure 14. Blood Plasma Fractionation Sales Share by Manufacturers in 2021
    Figure 15. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Blood Plasma Fractionation Players: Market Share by Revenue in 2021
    Figure 17. Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Blood Plasma Fractionation Sales Market Share by Region (2017-2022)
    Figure 19. Global Blood Plasma Fractionation Sales Market Share by Region in 2021
    Figure 20. Global Blood Plasma Fractionation Revenue Market Share by Region (2017-2022)
    Figure 21. Global Blood Plasma Fractionation Revenue Market Share by Region in 2021
    Figure 22. United States Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Blood Plasma Fractionation Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Blood Plasma Fractionation by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Blood Plasma Fractionation
    Figure 46. Manufacturing Process Analysis of Blood Plasma Fractionation
    Figure 47. Blood Plasma Fractionation Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed